Navigation Links
IOF urges systematic osteoporosis management after vertebral fracture augmentation
Date:8/1/2011

A working group of the International Osteoporosis Foundation (IOF) has issued a literature review of prospective controlled studies comparing the efficacy and safety of two minimally invasive techniques for vertebral augmentation after spine fracture: vertebroplasty (VP) and balloon kyphoplasty (BKP). The review also lists important recommendations to facilitate the comparison of future studies and highlights research questions still unresolved.

Vertebral fractures, most often due to osteoporosis, are associated with acute or chronic back pain, disability and kyphosis (stooped back). One in five women with a vertebral fracture will sustain another within a year, which may lead to a 'cascade' of fractures. Vertebral fractures impact severely on quality of life and may have serious health consequences such as spinal deformity, immobility, decreased pulmonary function, early satiety and impaired gait. Clinical vertebral fractures are also associated with an 8-fold increase in mortality.

Conservative treatment of vertebral fractures is typically through rest, pain medication, bracing and muscle relaxants. VP and BKP are two minimally invasive techniques that consist of inserting a bone cement into the compressed vertebra and stabilising the fracture.

In the studies observed, the review found that:

  • Overall, VP and BKP are relatively safe procedures and serious complications are rare.
  • In the short term, VP and BKP provide quicker pain relief and mobility recovery than does conservative treatment alone.
  • VP and BKP are able to stabilise the fracture and in some cases restore lost vertebral body height.
  • The added benefit of injecting cement over a sham-controlled surgery is still contentious.
  • The clinical outcome after VP and BKP appears to be dependent on the time elapsed between the fracture and the intervention.
  • The incidence of new (including adjacent) vertebral fractures are similar after VP or BKP, but longer term data are required.
  • Further studies are needed with standardised and systematic reporting of health outcomes and complications.

Kristina kesson, chair of the IOF Fracture Working Group and Professor at the Department of Orthopedics, Skne University Hospital Malm in Sweden, stated, "Referring physicians should be aware that VP and BKP are available options for the management of vertebral compression fractures, with possible clinical benefits to their patients in terms of acute pain relief and improved quality of life. However, longer follow-up of patients are needed to ensure the efficacy and safety of these techniques, which should not be considered as a substitute for the medical management of osteoporosis, vitally needed in these patients at high risk of other fractures."


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
41-229-940-100
International Osteoporosis Foundation
Source:Eurekalert

Related biology news :

1. Strong El Niño could bring increased sea levels, storm surges to US East Coast
2. Innovation Task Force urges approval of America COMPETES Act
3. Storm Surges Congress 2010 -- scientists from 30 countries meet in Hamburg
4. UF researcher urges caution in reducing blood pressure in patients with diabetes, coronary disease
5. SNM urges Congress to support CARE bill
6. FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract
7. Top scientific meeting urges coordinated response to economic and environmental crises
8. Molecular methods are not sufficient in systematics and evolution
9. Space agencies join forces to systematically observe climate variables
10. Experts discuss applying systematic review to the field of nutrition
11. Registration opens for first Middle East and Africa osteoporosis meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
(Date:1/22/2016)... January 22, 2016 ... addition of the  "Global Behavioral Biometric ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ... Behavioral Biometric Market 2016-2020"  report to ... and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ...
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... significant achievements are the result of the company,s laser ... iMedNet eClinical , it,s comprehensive, easy-to-use and highly ... --> Key MedNet growth achievements in 2015 ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... Amarantus BioScience Holdings, Inc. ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, ... (RPDD) from the US Food and Drug Administration (FDA) ... previously granted orphan drug designation (ODD) by the US ... Holdings, Inc. (OTCQB: AMBS), a biotechnology ...
(Date:2/4/2016)... New FDA action date of July 22, 2016   ... 22, 2016   --> - New FDA ... - Lifitegrast has the potential to be the only product approved ... and symptoms of dry eye disease in adults --> - ... the U.S. in the past decade indicated for the treatment of signs and ...
(Date:2/4/2016)... Church, VA (PRWEB) , ... ... ... first-year cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes place ... PA. The two-day event features 20+ speakers and activities such as workshops ...
(Date:2/4/2016)... MENLO PARK, Calif. , Feb. 4, 2016 ... the "Company"), a biopharmaceutical company focused on the development and ... present at the 18 th Annual BIO CEO ... 10:00 a.m. EST in New York, NY ... CEO, will provide an update on the ongoing clinical trial ...
Breaking Biology Technology: